Uploaded January 2025 | Updated September 2026, 3 weeks ago

---

Working with pluripotent stem cells (PSCs) and looking to establish processes that are scalable, closed and controlled?

Our extensive experience with allogeneic cell therapies has enabled us to develop robust processes to accelerate the therapeutic potential of PSCs, and we are interested to work with other groups who are looking for support with PSC expansion or iPSC lineage bias.

Learn more ➡️ ct.catapult.org.uk/how-we-work/challenge-themes#improving-scalability-and-control-of-allogeneic-cell-therapies